Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States
J Acquir Immune Defic Syndr
.
2018 Oct 1;79(2):e76-e78.
doi: 10.1097/QAI.0000000000001792.
Authors
Czarina N Behrends
1
,
Ann V Nugent
2
,
Don C Des Jarlais
2
,
Jemima A Frimpong
3
,
David C Perlman
2
,
Bruce R Schackman
1
Affiliations
1
Department of Healthcare Policy & Research, Weill Cornell Medical College, New York, NY.
2
Icahn School of Medicine at Mt. Sinai, New York, NY.
3
Carey Business School, John Hopkins University, Baltimore, MD.
PMID:
29985266
PMCID:
PMC6347107
DOI:
10.1097/QAI.0000000000001792
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
AIDS Serodiagnosis*
Hepatitis C / diagnosis*
Humans
Needle-Exchange Programs*
Substance Abuse, Intravenous / therapy
Syringes*
United States
Grants and funding
P30 DA011041/DA/NIDA NIH HHS/United States
P30 DA040500/DA/NIDA NIH HHS/United States
R01 DA027379/DA/NIDA NIH HHS/United States